(Q71121145)
Statements
Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies (English)
M R Bishop
E Bayever
J G Sharp
T C Greiner
B L Copple
R Ruddon
G Zon
J Spinolo
M Arneson
J O Armitage
scientific article published on 01 April 1996